| Literature DB >> 25672474 |
Dorota Kostrzewa-Nowak1, Robert Nowak1, Zbigniew Jastrzębski2, Aleksandra Zarębska2, Marta Bichowska2, Izabela Drobnik-Kozakiewicz2, Łukasz Radzimiński2, Agata Leońska-Duniec3, Krzysztof Ficek3, Paweł Cięszczyk4.
Abstract
BACKGROUND: Numerous data suggest that aerobic-type exercise improves lipoprotein-lipid profiles, cardiorespiratory fitness and body composition in young women. The aim of this study was to evaluate the biological response to high-low impact aerobic fitness among young women.Entities:
Keywords: body composition; overweight; physical fitness; women
Mesh:
Substances:
Year: 2015 PMID: 25672474 PMCID: PMC4401316 DOI: 10.11613/BM.2015.013
Source DB: PubMed Journal: Biochem Med (Zagreb) ISSN: 1330-0962 Impact factor: 2.313
The impact of 12-week-long aerobic training programme on body composition among underweight, normal weight and overweight young women.
| 21 (19-24) | / | 22 (19-23) | 22 (19-23) | / | |||||
| 171.0 (166.0-174.0) | / | 164.5 (163.0-168.5) | 163.5 (159.9-167.0) | / | |||||
| 51.5 (49.0-52.9) | 55.7 (51.3-56.6) | 0.005* | 57.2 (55.4-61.8) | 58.1 (55.3-60.7) | 0.754 | 69.7 (67.0-71.7) | 65.4 (62.5-67.9) | 0.003* | |
| 17.9 (17.5-18.1) | 18.8 (18.5-19.3) | 0.005* | 21.3 (20.6-22.1) | 21.4 (20.4-22.2) | 0.239 | 26.0 (25.8-27.4) | 24.7 (24.1-24.9) | 0.003* | |
| 43.7 (41.9-45.0) | 44.0 (42.7-45.8) | 0.475 | 44.3 (43.5-46.1) | 44.6 (43.5-46.7) | 0.784 | 48.3 (45.6-50.1) | 46.2 (43.9-48.2) | 0.002* | |
| 32.0 (30.7-32.9) | 32.2 (30.9-33.5) | 0.878 | 32.5 (31.8-33.7) | 32.7 (31.8-34.2) | 0.754 | 35.3 (33.6-36.7) | 34.9 (33.4-36.0) | 0.036* | |
| 20 (16-22) | 18 (15-20) | 0.093 | 24 (21-26) | 23 (20-26) | 0.255 | 30 (29-32) | 27 (26-28) | 0.002* | |
| 5877 (5676-5981) | 5879 (5604-5920) | 0.333 | 5913 (5814-6090) | 5908 (5824-6097) | 0.410 | 6325 (6123-6424) | 6271 (6119-6426) | 0.374 | |
| 7.8 (5.8-9.8) | 7.7 (6.2-15.4) | 0.386 | 10.5 (9.2-11.7) | 9.8 (8.1-13.0) | 0.875 | 15.2 (14.9-18.9) | 12.3 (9.4-13.7) | 0.002* | |
| 11.0 (9.0-16.0) | 12.3 (10.0-19.0) | 0.575 | 17.7 (14.9-18.3) | 14.5 (11.5-17.6) | 0.099 | 25.6 (22.9-28.2) | 21.0 (18.6-22.2) | 0.002* | |
| 9.7 (7.4-11.2) | 9.0 (8.0-13.4) | 0.799 | 13.1 (11.8-14.9) | 11.5 (9.9-17.0) | 0.583 | 19.4 (16.0-24.0) | 15.6 (13.0-19.3) | 0.002* | |
| 5.0 (4.6-7.0) | 6.5 (5.0-14.8) | 0.308 | 7.6 (5.1-11.4) | 7.1 (5.7-10.2) | 0.906 | 12.2 (10.5-14.9) | 10.7 (8.2-12.7) | 0.041* | |
| 4.8 (3.0-6.2) | 8.1 (5.0-11.2) | 0.028* | 7.8 (4.2-11.7) | 11.6 (9.6-13.0) | 0.059 | 13.4 (11.3-15.9) | 11.5 (9.3-14.9) | 0.023* | |
Data are presented as median (interquartile range), age is presented as median (min-max). BMI – body mass index; FFM – fat free mass; TBW – total body water; PE – percentage of fat; BMR – basal metabolic range; ST – skinfold thickness. The significance levels of the differences observed between analysed time-points were assessed using Wilcoxon’s matched pairs test. *difference statistically significant.
The effect of aerobic-type exercise training on cardiorespiratory fitness measures (before and after the training programme).
| 36.85 (35.15-39.04) | 39.34 (34.78-43.13) | 0.047* | 32.45 (29.46-37.32) | 35.03 (31.18-40.25) | 0.099 | 32.38 (28.04-35.55) | 33.20 (29.08-35.79) | 0.814 | |
| 79.27 (63.06-90.77) | 84.90 (77.75-107.70) | 0.059 | 74.22 (68.08-89.98) | 78.73 (71.54-88.98) | 0.209 | 68.41 (65.73-69.84) | 81.53 (79.00-95.02) | 0.002* | |
| 186 (183-189) | 187 (184-194) | 0.192 | 192 (185-197) | 190 (184-197) | 0.401 | 188 (185-192) | 187 (183-192) | 0.666 | |
| 29.88 (28.14-30.81) | 29.64 (25.34-32.47) | 0.838 | 25.01 (21.53-26.19) | 28.22 (24.81-30.23) | 0.099 | 25.57 (23.11-28.36) | 23.63 (22.34-26.87) | 0.346 | |
Data are presented as median (interquartile range). VO2max – maximum oxygen uptake; VEmax – maximum minute ventilation; HRmax – maximum heart rate; VO2/AT – anaerobic threshold. The significance levels of the differences observed between analysed time-points were assessed using Wilcoxon’s matched pairs test. *difference statistically significant.
The impact of 12 weeks of aerobic training programme on complete blood count and blood lipid profile in underweight, normal weight and overweight young women.
| 5.7 (5.2-6.3) | 5.9 (5.0-7.3) | 0.284 | 6.7 (6.1-7.1) | 5.8 (5.0-6.6) | 0.062 | 5.8 (5.0-7.9) | 5.5 (4.8-6.8) | 0.477 | |
| 4.62 (4.44-4.75) | 4.48 (4.24-4.62) | 0.074 | 4.33 (4.23-4.59) | 4.55 (4.36-4.74) | 0.209 | 4.43 (4.19-4.75) | 4.46 (4.13-4.82) | 0.239 | |
| 13.6 (13.2-13.7) | 13.2 (12.6-14.0) | 0.203 | 13.2 (12.7-13.7) | 13.7 (13.1-14.0) | 0.328 | 13.5 (12.8-13.8) | 13.4 (12.5-14.0) | 0.789 | |
| 41 (39-41) | 39 (39-41) | 0.221 | 39 (38-41) | 40 (39-43) | 0.131 | 39 (38-40) | 40 (38-41) | 0.698 | |
| 87.1 (86.3-88.7) | 88.5 (86.4-91.5) | 0.308 | 88.0 (85.4-90.4) | 89.0 (86.9-91.7) | 0.239 | 88.1 (86.2-91.6) | 88.2 (84.8-92.3) | 0.367 | |
| 29.2 (28.7-29.8) | 29.7 (28.1-30.7) | 0.799 | 30.1 (29.3-31.0) | 29.8 (29.3-30.6) | 0.099 | 30.1 (28.7-31.5) | 29.8 (28.3-31.7) | 0.142 | |
| 33.4 (32.7-33.8) | 33.2 (32.4-34.1) | 0.183 | 33.9 (33.4-34.4) | 33.5 (33.2-34.1) | 0.168 | 34.0 (33.1-34.6) | 33.7 (32.8-34.4) | 0.625 | |
| 249 (232-282) | 258 (239-275) | 0.575 | 265 (226-288) | 257 (232-297) | 0.158 | 235 (226-268) | 242 (210-279) | 0.814 | |
| 1.01 (0.85-1.07) | 0.88 (0.76-0.96) | 0.398 | 0.94 (0.84-1.18) | 0.66 (0.62-0.97) | 0.138 | 1.26 (1.15-1.33) | 0.86 (0.66-0.96) | 0.003* | |
| 4.78 (4.29-4.99) | 4.33 (4.19-4.68) | 0.139 | 4.48 (4.26-4.77) | 4.45 (4.11-4.56) | 0.136 | 5.22 (4.93-6.13) | 4.21 (3.93-4.55) | 0.003* | |
| 1.67 (1.62-1.75) | 1.63 (1.47-1.90) | 0.387 | 1.79 (1.65-1.92) | 1.52 (1.26-2.02) | 0.091 | 1.70 (1.40-2.07) | 1.52 (1.36-1.63) | 0.026* | |
| 2.45 (2.17-2.71) | 2.18 (2.05-2.33) | 0.234 | 2.24 (2.10-2.50) | 2.15 (1.93-2.28) | 0.074 | 2.93 (2.44-3.34) | 2.15 (1.88-2.35) | 0.012* | |
Data are presented as median (interquartile range). WBC – white blood cells; RBC – red blood cells; HGB – haemoglobin; HTC – haematocrit; MCV – mean corpuscular volume; MCH – mean corpuscular haemoglobin; MCHC – mean corpuscular haemoglobin concentration; PLT – platelets; Tg – triglycerides; Chol – total cholesterol; HDL – high-density lipoprotein cholesterol; LDL – low-density lipoprotein cholesterol. The significance levels of the differences observed between analysed time-points were assessed using Wilcoxon’s matched pairs test. *difference statistically significant.